Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | CDC25B | P30305 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6405726 | 0.88 | ALDH1A1 (0.66) | TSHRALDH1A1HSD17B10TDP1KMT2A | |
| SCHEMBL8607117 | 0.87 | MEN1 (0.57) | TSHRALDH1A1HSD17B10TDP1KMT2A | |
| SCHEMBL29372521 | 0.87 | MEN1 (0.57) | TSHRALDH1A1HSD17B10TDP1KMT2A | |
| SCHEMBL10707097 | 0.87 | MEN1 (0.57) | TSHRALDH1A1HSD17B10TDP1KMT2A | |
| SCHEMBL29302 | 0.87 | MEN1 (0.57) | TSHRALDH1A1HSD17B10TDP1KMT2A | |
| SCHEMBL19668120 | 0.87 | MEN1 (0.57) | TSHRALDH1A1HSD17B10TDP1KMT2A | |
| SCHEMBL31069910 | 0.87 | MEN1 (0.57) | TSHRALDH1A1HSD17B10TDP1KMT2A | |
| SCHEMBL271491 | 0.86 | TSHR (0.68) | TSHRALDH1A1HSD17B10TDP1KMT2A | |
| SCHEMBL31020921 | 0.86 | TSHR (0.68) | TSHRALDH1A1HSD17B10TDP1KMT2A | |
| Dibutyl Phthalate SCHEMBL28523512 | 0.86 | TSHR (0.68) | TSHRALDH1A1HSD17B10TDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4146153-B1 | AN ANTIPERSPIRANT COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2023-11-01 | — | — | EP | disclosed |
| US-20230127509-A1 | An Antiperspirant Composition | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-04-27 | — | — | US | disclosed |
| US-20230124656-A1 | An Antiperspirant Composition | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-04-20 | — | — | US | disclosed |
| EP-4146152-A1 | AN ANTIPERSPIRANT COMPOSITION | Unilever IP Holdings B.V. (NL) | 2023-03-15 | — | — | EP | disclosed |
| EP-4146153-A1 | AN ANTIPERSPIRANT COMPOSITION | Unilever IP Holdings B.V. (NL) | 2023-03-15 | — | — | EP | disclosed |
| WO-2021224133-A1 | AN ANTIPERSPIRANT COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2021-11-11 | — | — | WO | disclosed |
| WO-2021224167-A1 | AN ANTIPERSPIRANT COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2021-11-11 | — | — | WO | disclosed |
| CN-101188948-A | Lignan-containing compositions | ARCHER DANIELS MIDLAND CO (US) | 2008-05-28 | — | — | CN | disclosed |
| EP-1897559-A1 | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations | Cydex Inc. (US) | 2008-03-12 | — | — | EP | disclosed |
| EP-1897560-A1 | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations | Cydex Inc. (US) | 2008-03-12 | — | — | EP | disclosed |
| US-4429066-A | AUTOMOBILES AND TRUCKS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-01-31 | — | — | US | disclosed |
| US-4416941-A | AUTOMOTIVE PAINTS | E. I. DU PONT DE NEMOURS & CO. (US) | 1983-11-22 | — | — | US | disclosed |
| US-4411951-A | ACRYLIC ESTER RESIN CROSS LINKED WITH MELAMINE-FORMALDEHYDE RESIN BONDER | E. I. DU PONT DE NEMOURS & CO. (US) | 1983-10-25 | — | — | US | disclosed |
| US-4404248-A | AUTOMOBILES; TRUCKS; AIRCRAFT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-09-13 | — | — | US | disclosed |
| US-4396680-A | Substrate coated with crater resistant acrylic enamel | E. I. DU PONT DE NEMOURS AND CO. (US) | 1983-08-02 | — | — | US | disclosed |
| US-4371657-A | AMINO RESIN CROSSLINKING | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-02-01 | — | — | US | disclosed |
| US-4330458-A | High solids coating composition of a blend of a low molecular weight acrylic polymer and a medium molecular weight acrylic polymer and an alkylated melamine cross-linking agent | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-05-18 | — | — | US | disclosed |
| US-4276212-A | ACRYLIC ESTER COPOLYMER INCLUDING A HYDROXYALKYL ACRYLATE AND CHAIN TRANSFER AGENT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-06-30 | — | — | US | disclosed |
| EP-0029598-A1 | An improved high solids coating composition of a low molecular weight acrylic polymer and a polyisocyanate cross-linking agent, and a substrate coated therewith | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-06-03 | — | — | EP | disclosed |
| EP-0029596-A1 | An improved high solids coating composition of a low molecular weight acrylic polymer and a nitrogen resin cross-linking agent, and a substrate coated therewith | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230127509-A1 | An Antiperspirant Composition | CUTA, POLR1C, PUF60 | TSHR 4500/4885ALDH1A1 1386/4885HSD17B10 782/4885 |
| US-20230124656-A1 | An Antiperspirant Composition | POLR1C, CUTA, PUF60 | TSHR 4194/4885ALDH1A1 1819/4885HSD17B10 793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.